| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |